Search results
Understand the peri-operative management, staging, and surgical oncology principles for cutaneous MCT in dogs and cats, and the indications for adjunctive radiation therapy or chemotherapy in conjunction with surgery. Understand treatment options for non-resectable MCTs.
Treatment for an infectious (bacterial) polyarthritis involves antibiotic therapy. Treatment for immune-mediated polyarthritis involves the use of a single drug or multiple drugs to “turn off” or suppress the immune system.
Blood smear in a dog with immune-mediated haemolytic anaemia. Note the anisocytosis (variable size of red blood cells) and polychromasia (presence of polychromatophils: immature red blood cells that are larger and more basophilic; green arrows).
1 kwi 2005 · In addition to the high response rate, the median progression-free survival time of treated dogs was 1,031 days. Radiation therapy, either curative-intent or palliative, to treat nonresectable cutaneous mast cell tumors should be considered a viable treatment option in dogs.
1 mar 2011 · The treatment of both nonerosive and erosive IMPA involves immunosuppressive, immunomodulating, and disease-modifying drugs. In dogs with nonerosive IMPA, the prognosis and response to treatment vary according to cause but is often guarded to good, with many patients responding to single agent or combination drug therapy.
1 gru 2008 · Article. A careful diagnostic process will help you determine whether your veterinary patients will require long-term immunosuppressive therapy. Autoimmune hemolytic anemia, or immune-mediated hemolytic anemia (IMHA), is a complex disease in which hemolysis occurs because of antierythrocyte antibody production.
Contact your local BluePearl for services available at that location. Find a Hospital Near Me. BluePearl veterinary specialists in internal medicine use a variety of tests to diagnose severe chronic illnesses or symptoms that appear suddenly.
